Entera Bio Ltd. — Director's Dealing 2024

Jan 4, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2024-01-01

Reporting Person: Taitel Haya (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-01	Stock Option (right to buy)	$0.60	A	108333	Acquired	2034-01-01	Ordinary Shares, par value NIS 0.0000769 per share (108333)	Direct

Footnotes

F1: The options vest ratably on a quarterly basis over a one-year period that commenced on January 1, 2024.